HER2 Support Group Forums - View Single Post - ABCSG 18: monoclonal antibody increases disease-free survival in breast cancer

News · 12-10-2015, 10:30 AM

Giving a monoclonal antibody (denosumab) as adjuvant therapy with aromatase inhibitors in postmenopausal, hormone-receptor-positive breast cancer patients reduces the relapse rate by 18%.

More...

12-10-2015, 10:30 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,105	ABCSG 18: monoclonal antibody increases disease-free survival in breast cancer Giving a monoclonal antibody (denosumab) as adjuvant therapy with aromatase inhibitors in postmenopausal, hormone-receptor-positive breast cancer patients reduces the relapse rate by 18%. More...